Skip to main content

Optimization of the gRNA Vector Dose Enhances Long-Term Systemic AAV CRISPR Therapy in Muscular Dystrophy

Publication ,  Conference
Hakim, CH; Wasala, N; Nelson, C; Wasala, L; Yue, Y; Zhang, K; Nance, M; Kodippili, K; Pan, X; Yang, N; Chen, S-J; Gersbach, C; Duan, D
Published in: MOLECULAR THERAPY
May 1, 2018

Duke Scholars

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

May 1, 2018

Volume

26

Issue

5

Start / End Page

370 / 370

Location

Chicago, IL

Publisher

CELL PRESS

Conference Name

21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hakim, C. H., Wasala, N., Nelson, C., Wasala, L., Yue, Y., Zhang, K., … Duan, D. (2018). Optimization of the gRNA Vector Dose Enhances Long-Term Systemic AAV CRISPR Therapy in Muscular Dystrophy. In MOLECULAR THERAPY (Vol. 26, pp. 370–370). Chicago, IL: CELL PRESS.
Hakim, Chady H., Nalinda Wasala, Christopher Nelson, Lakmini Wasala, Yongping Yue, Keqing Zhang, Michael Nance, et al. “Optimization of the gRNA Vector Dose Enhances Long-Term Systemic AAV CRISPR Therapy in Muscular Dystrophy.” In MOLECULAR THERAPY, 26:370–370. CELL PRESS, 2018.
Hakim CH, Wasala N, Nelson C, Wasala L, Yue Y, Zhang K, et al. Optimization of the gRNA Vector Dose Enhances Long-Term Systemic AAV CRISPR Therapy in Muscular Dystrophy. In: MOLECULAR THERAPY. CELL PRESS; 2018. p. 370–370.
Hakim, Chady H., et al. “Optimization of the gRNA Vector Dose Enhances Long-Term Systemic AAV CRISPR Therapy in Muscular Dystrophy.” MOLECULAR THERAPY, vol. 26, no. 5, CELL PRESS, 2018, pp. 370–370.
Hakim CH, Wasala N, Nelson C, Wasala L, Yue Y, Zhang K, Nance M, Kodippili K, Pan X, Yang N, Chen S-J, Gersbach C, Duan D. Optimization of the gRNA Vector Dose Enhances Long-Term Systemic AAV CRISPR Therapy in Muscular Dystrophy. MOLECULAR THERAPY. CELL PRESS; 2018. p. 370–370.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

May 1, 2018

Volume

26

Issue

5

Start / End Page

370 / 370

Location

Chicago, IL

Publisher

CELL PRESS

Conference Name

21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences